Epredia Holdings Ltd.

Epredia is a global leader in precision cancer diagnostics and histopathology equipment with over 85 years of operational history. The company manufactures and supplies a comprehensive range of histology instruments, tissue processing systems, slide preparation equipment, and digital pathology solutions for pathology laboratories and cancer diagnostic centers worldwide. Core product lines include tissue processors (Revos Rotational Tissue Processor), slide printing systems (SlideMate Laser with 600dpi laser technology and LIS connectivity), and digital pathology imaging platforms (E1000 Dx Digital Pathology Solution). Epredia holds FDA 510(k) clearance for its E1000 Dx whole-slide imaging system, positioning the company at the intersection of traditional histopathology workflow automation and emerging digital pathology adoption. The company is a subsidiary of PHC Holdings Corporation (TSE: 6523), a major Japanese healthcare conglomerate. Epredia serves hospital pathology departments, reference laboratories, academic medical centers, and clinical cancer diagnostic networks. The product portfolio emphasizes precision, workflow optimization, and integration with laboratory information systems (LIS) to enhance diagnostic accuracy and throughput in cancer pathology workflows.